Therapeutic opportunity in innate immune response induction by oncogene-targeted drugs

Future Med Chem. 2019 May;11(10):1083-1086. doi: 10.4155/fmc-2018-0292. Epub 2019 May 14.
No abstract available

Keywords: MAPK; innate immune response; oncogene-targeted drugs; precision medicine; tyrosine kinase inhibitors.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents, Immunological / pharmacology*
  • Humans
  • Immunity, Innate / drug effects*
  • Molecular Targeted Therapy
  • Neoplasm, Residual / drug therapy
  • Neoplasm, Residual / immunology
  • Neoplasms / drug therapy*
  • Neoplasms / immunology
  • Protein Kinase Inhibitors / pharmacology

Substances

  • Antineoplastic Agents, Immunological
  • Protein Kinase Inhibitors